Eden Research (LON:EDEN) Announces Earnings Results

Eden Research (LON:EDEN) posted its quarterly earnings results on Wednesday. The company reported GBX (0.36) earnings per share for the quarter, Digital Look Earnings reports. Eden Research had a negative return on equity of 15.05% and a negative net margin of 44.31%.

Eden Research Stock Down 6.9%

EDEN stock opened at GBX 2.19 on Wednesday. The firm has a market cap of £17.57 million, a PE ratio of -4.93 and a beta of 1.57. The company has a current ratio of 2.25, a quick ratio of 2.42 and a debt-to-equity ratio of 1.43. The company has a fifty day simple moving average of GBX 2.73 and a 200 day simple moving average of GBX 3.17. Eden Research has a 1 year low of GBX 1.96 and a 1 year high of GBX 5.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.